Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; Relationship to apoptosis and bcl-2 protein expression

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2313-2319

  Tanji, Nozomu ^a   Kikugawa, Tadahiko ^a   Yokoyama, Masayoshi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bcl 2; Cyclooxygenase; Immunohistochemistry; Prostatic adenocarcinoma

Indexed keywords

ANDROGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GONADORELIN; PROTEIN BCL 2;

ADULT; AGED; ANDROGEN THERAPY; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; ENZYME LOCALIZATION; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ADENOCARCINOMA; APOPTOSIS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033866914     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. DuBois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van de Putte LBA and Lipsky PE: Cyclooxygenases in biology and disease. FASEB J 12; 1063-1073, 1998.
2. Funk CD, Funk LB, Kennedy ME, Pong AS and Fitzgerald GA: Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 5; 2304-2312, 1991.
3. Hla T and Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89: 7384-7388, 1992.
4. DeWitt DL: Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochem Biophys Acta 1083: 121-134, 1991.
5. Herschman HR: Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60: 281-319, 1991.
6. O'Banion MK, Sadowski HB, Winn V and Young DA: A serum- and glucocortinoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266: 23261-23267, 1991.
7. Kujubu DA, Flecher BS, Varnum BC, Lim RW and Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 166: 12866-12872, 1991.
8. Han JW, Sadowski H, Young DA and Macara IG: Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts. Proc Natl Acad Sci USA 87: 3373-3377, 1990.
9. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB and Dannenberg AJ: Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56; 4424-4429, 1996.
10. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenases 2 gene expression in human colorectal adenomas and adenbcarcinomas. Gastroenterology 707; 1183-1188, 1994.
11. Ristimaki A, Honkanen N, Jankala H, Sipponen P and Harkonen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280, 1997.
12. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55; 2556-2559, 1995.
13. Leong J, Hughes-Fulford M, Rakhlin N, Habib A, Maclouf J and Goldyne ME: Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 224; 79-87, 1996.
14. Tsujii M and Dubois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
15. Liu XH, Yao S, Kirschenbaum A and Levine AC: NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 55; 4245-4249, 1998.
16. Japanese Urological Association and the Japanese Pathological Society eds. General Rule for Clinical and Pathological Studies on Prostatic Cancer in Japan (2nd ed.) (in Japanese). Tokyo, Kanehara Publishing Co., 1992, pp 66.
17. Mostofi FK, Sesterhenn I and Sobin LH: Histological typing of prostatic tumors. International Histological Classification of Tumours (No 22 Geneva). World Health Organization, 1980.
18. Wyllie AH, Kerr JFR and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 65: 251-306, 1980.
19. Aihara M, Truong LD, Dunn JK, Wheeler TM, Scardino PT and Thompson TC: The frequency of apoptotic bodies positively correlates grade in prostate cancer. Hum Pathol 25: 797-801, 1994.
20. Tanji N, Yokoyama M, Sugamoto T, Takeuchi M and Terada N: Apoptosis in prostatic adenocarcinomas; A study of relationship to Ki-67 and Bcl-2 expression. Anticancer Res 18: 1111-1116, 1998.